Unknown

Dataset Information

0

Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection.


ABSTRACT: The interaction of antibodies, dengue virus (DENV), and monocytes can result in either immunity or enhanced virus infection. These opposing outcomes of dengue antibodies have hampered dengue vaccine development. Recent studies have shown that antibodies neutralize DENV by either preventing virus attachment to cellular receptors or inhibiting viral fusion intracellularly. However, whether the antibody blocks attachment or fusion, the resulting immune complexes are expected to be phagocytosed by Fc gamma receptor (Fc?R)-bearing cells and cleared from circulation. This suggests that only antibodies that are able to block fusion intracellularly would be able to neutralize DENV upon Fc?R-mediated uptake by monocytes whereas other antibodies would have resulted in enhancement of DENV replication. Using convalescent sera from dengue patients, we observed that neutralization of the homologous serotypes occurred despite Fc?R-mediated uptake. However, Fc?R-mediated uptake appeared to be inhibited when neutralized heterologous DENV serotypes were used instead. We demonstrate that this inhibition occurred through the formation of viral aggregates by antibodies in a concentration-dependent manner. Aggregation of viruses enabled antibodies to cross-link the inhibitory Fc?RIIB, which is expressed at low levels but which inhibits Fc?R-mediated phagocytosis and hence prevents antibody-dependent enhancement of DENV infection in monocytes.

SUBMITTER: Chan KR 

PROVIDER: S-EPMC3145677 | biostudies-literature | 2011 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection.

Chan Kuan Rong KR   Zhang Summer Li-Xin SL   Tan Hwee Cheng HC   Chan Ying Kai YK   Chow Angelia A   Lim Angeline Pei Chiew AP   Vasudevan Subhash G SG   Hanson Brendon J BJ   Ooi Eng Eong EE  

Proceedings of the National Academy of Sciences of the United States of America 20110711 30


The interaction of antibodies, dengue virus (DENV), and monocytes can result in either immunity or enhanced virus infection. These opposing outcomes of dengue antibodies have hampered dengue vaccine development. Recent studies have shown that antibodies neutralize DENV by either preventing virus attachment to cellular receptors or inhibiting viral fusion intracellularly. However, whether the antibody blocks attachment or fusion, the resulting immune complexes are expected to be phagocytosed by F  ...[more]

Similar Datasets

| S-EPMC2820409 | biostudies-literature
2014-12-30 | E-MTAB-3138 | biostudies-arrayexpress
2017-03-08 | E-MTAB-4692 | biostudies-arrayexpress
| S-EPMC5858873 | biostudies-literature